Inhibition of AKT Signaling Uncouples T Cell Differentiation From Expansion for Receptor-Engineered Adoptive Immunotherapy

JCI insight - United States
doi 10.1172/jci.insight.95103
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Enrichment and Expansion With Nanoscale Artificial Antigen Presenting Cells for T Cell Adoptive Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

BET Bromodomain Inhibition Enhances T Cell Persistence and Function in Adoptive Immunotherapy Models

Journal of Clinical Investigation
Medicine
2016English

Engineered T Cells Bypass Death Signaling and Bolster Immunotherapy

Cancer Discovery
Oncology
2019English

Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology

Immunity
Infectious DiseasesAllergyImmunology
2013English

Crosstalk Pathway for Inhibition of Glucocorticoid-Induced Apoptosis by T Cell Receptor Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Rebuilding Human Leukocyte Antigen Class II-Restricted Minor Histocompatibility Antigen Specificity in Recall Antigen-Specific T Cells by Adoptive T Cell Receptor Transfer: Implications for Adoptive Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2007English

Adoptive Immunotherapy of Cancer Using CD4+ T Cells

Current Opinion in Immunology
AllergyImmunology
2009English

Chimaeric Antigen Receptor T-Cell Therapy for Tumour Immunotherapy

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

The Emerging Role of in Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy